nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—ALB—multiple sclerosis	0.219	1	CbGaD
Nortriptyline—CYP2E1—Fingolimod—multiple sclerosis	0.087	0.207	CbGbCtD
Nortriptyline—CYP2D6—Fingolimod—multiple sclerosis	0.0414	0.0989	CbGbCtD
Nortriptyline—CYP2E1—Mitoxantrone—multiple sclerosis	0.0409	0.0975	CbGbCtD
Nortriptyline—ALB—Prednisone—multiple sclerosis	0.0328	0.0783	CbGbCtD
Nortriptyline—CYP3A4—Fingolimod—multiple sclerosis	0.0263	0.0629	CbGbCtD
Nortriptyline—CYP2C19—Prednisone—multiple sclerosis	0.0213	0.0508	CbGbCtD
Nortriptyline—CYP2E1—Dexamethasone—multiple sclerosis	0.0212	0.0506	CbGbCtD
Nortriptyline—CYP3A4—Methylprednisolone—multiple sclerosis	0.017	0.0405	CbGbCtD
Nortriptyline—CYP3A5—Dexamethasone—multiple sclerosis	0.0165	0.0393	CbGbCtD
Nortriptyline—ALB—Methotrexate—multiple sclerosis	0.0165	0.0393	CbGbCtD
Nortriptyline—CYP2C19—Dexamethasone—multiple sclerosis	0.0133	0.0317	CbGbCtD
Nortriptyline—HTR2A—trigeminal nucleus—multiple sclerosis	0.013	0.17	CbGeAlD
Nortriptyline—CYP3A4—Triamcinolone—multiple sclerosis	0.0129	0.0307	CbGbCtD
Nortriptyline—CYP3A4—Mitoxantrone—multiple sclerosis	0.0124	0.0296	CbGbCtD
Nortriptyline—CYP2C9—Dexamethasone—multiple sclerosis	0.011	0.0263	CbGbCtD
Nortriptyline—CYP3A4—Betamethasone—multiple sclerosis	0.011	0.0263	CbGbCtD
Nortriptyline—CYP3A4—Prednisolone—multiple sclerosis	0.0109	0.026	CbGbCtD
Nortriptyline—CYP3A4—Prednisone—multiple sclerosis	0.0103	0.0245	CbGbCtD
Nortriptyline—CYP2D6—Dexamethasone—multiple sclerosis	0.0101	0.0241	CbGbCtD
Nortriptyline—CYP3A4—Dexamethasone—multiple sclerosis	0.00642	0.0153	CbGbCtD
Nortriptyline—HTR2A—trigeminal nerve—multiple sclerosis	0.00341	0.0447	CbGeAlD
Nortriptyline—HTR2A—pons—multiple sclerosis	0.0024	0.0315	CbGeAlD
Nortriptyline—SLC6A2—nerve—multiple sclerosis	0.00207	0.0272	CbGeAlD
Nortriptyline—DRD2—nerve—multiple sclerosis	0.00189	0.0248	CbGeAlD
Nortriptyline—HTR2A—pineal body—multiple sclerosis	0.00171	0.0225	CbGeAlD
Nortriptyline—HTR2A—peripheral nervous system—multiple sclerosis	0.00159	0.021	CbGeAlD
Nortriptyline—HTR2A—nerve—multiple sclerosis	0.00124	0.0163	CbGeAlD
Nortriptyline—CHRM4—nervous system—multiple sclerosis	0.00108	0.0142	CbGeAlD
Nortriptyline—HTR2C—brainstem—multiple sclerosis	0.00106	0.014	CbGeAlD
Nortriptyline—CHRM4—central nervous system—multiple sclerosis	0.00104	0.0136	CbGeAlD
Nortriptyline—SLC6A4—brainstem—multiple sclerosis	0.00101	0.0133	CbGeAlD
Nortriptyline—HTR6—nervous system—multiple sclerosis	0.000965	0.0127	CbGeAlD
Nortriptyline—HTR6—central nervous system—multiple sclerosis	0.000929	0.0122	CbGeAlD
Nortriptyline—HTR1A—brainstem—multiple sclerosis	0.000896	0.0118	CbGeAlD
Nortriptyline—SLC6A2—brainstem—multiple sclerosis	0.000888	0.0117	CbGeAlD
Nortriptyline—CHRM5—nervous system—multiple sclerosis	0.000843	0.0111	CbGeAlD
Nortriptyline—ADRA1A—brainstem—multiple sclerosis	0.000826	0.0108	CbGeAlD
Nortriptyline—CHRM4—brain—multiple sclerosis	0.000824	0.0108	CbGeAlD
Nortriptyline—CHRM5—central nervous system—multiple sclerosis	0.000811	0.0107	CbGeAlD
Nortriptyline—DRD2—brainstem—multiple sclerosis	0.000809	0.0106	CbGeAlD
Nortriptyline—DRD2—retina—multiple sclerosis	0.000781	0.0103	CbGeAlD
Nortriptyline—ADRA1B—nervous system—multiple sclerosis	0.00077	0.0101	CbGeAlD
Nortriptyline—ADRA1D—nervous system—multiple sclerosis	0.000753	0.0099	CbGeAlD
Nortriptyline—HTR2C—medulla oblongata—multiple sclerosis	0.000742	0.00975	CbGeAlD
Nortriptyline—ADRA1B—central nervous system—multiple sclerosis	0.000741	0.00974	CbGeAlD
Nortriptyline—HTR6—brain—multiple sclerosis	0.000737	0.00969	CbGeAlD
Nortriptyline—ORM1—spinal cord—multiple sclerosis	0.000736	0.00967	CbGeAlD
Nortriptyline—ADRA1D—central nervous system—multiple sclerosis	0.000725	0.00953	CbGeAlD
Nortriptyline—HTR2C—midbrain—multiple sclerosis	0.000678	0.00891	CbGeAlD
Nortriptyline—HTR2C—spinal cord—multiple sclerosis	0.000662	0.00869	CbGeAlD
Nortriptyline—CHRM5—brain—multiple sclerosis	0.000644	0.00846	CbGeAlD
Nortriptyline—SLC6A4—midbrain—multiple sclerosis	0.000643	0.00845	CbGeAlD
Nortriptyline—SLC6A4—spinal cord—multiple sclerosis	0.000627	0.00824	CbGeAlD
Nortriptyline—ORM1—nervous system—multiple sclerosis	0.00062	0.00815	CbGeAlD
Nortriptyline—SLC6A2—medulla oblongata—multiple sclerosis	0.000619	0.00814	CbGeAlD
Nortriptyline—ORM1—central nervous system—multiple sclerosis	0.000597	0.00785	CbGeAlD
Nortriptyline—ADRA1B—brain—multiple sclerosis	0.000589	0.00773	CbGeAlD
Nortriptyline—CHRM2—nervous system—multiple sclerosis	0.000578	0.0076	CbGeAlD
Nortriptyline—ADRA1D—brain—multiple sclerosis	0.000576	0.00756	CbGeAlD
Nortriptyline—HTR1A—midbrain—multiple sclerosis	0.000571	0.0075	CbGeAlD
Nortriptyline—HTR2C—nervous system—multiple sclerosis	0.000558	0.00733	CbGeAlD
Nortriptyline—HTR1A—spinal cord—multiple sclerosis	0.000557	0.00732	CbGeAlD
Nortriptyline—CHRM2—central nervous system—multiple sclerosis	0.000557	0.00732	CbGeAlD
Nortriptyline—HTR2C—central nervous system—multiple sclerosis	0.000537	0.00705	CbGeAlD
Nortriptyline—HTR2A—brainstem—multiple sclerosis	0.000534	0.00701	CbGeAlD
Nortriptyline—SLC6A4—nervous system—multiple sclerosis	0.000529	0.00694	CbGeAlD
Nortriptyline—CHRM1—nervous system—multiple sclerosis	0.000526	0.00692	CbGeAlD
Nortriptyline—DRD2—midbrain—multiple sclerosis	0.000516	0.00678	CbGeAlD
Nortriptyline—HTR2A—retina—multiple sclerosis	0.000515	0.00677	CbGeAlD
Nortriptyline—SLC6A4—central nervous system—multiple sclerosis	0.000509	0.00669	CbGeAlD
Nortriptyline—CHRM1—central nervous system—multiple sclerosis	0.000507	0.00666	CbGeAlD
Nortriptyline—CYP2D6—brainstem—multiple sclerosis	0.000486	0.00639	CbGeAlD
Nortriptyline—CHRM3—nervous system—multiple sclerosis	0.000471	0.00619	CbGeAlD
Nortriptyline—HTR1A—nervous system—multiple sclerosis	0.000469	0.00617	CbGeAlD
Nortriptyline—SLC6A2—nervous system—multiple sclerosis	0.000465	0.00611	CbGeAlD
Nortriptyline—CHRM3—central nervous system—multiple sclerosis	0.000454	0.00596	CbGeAlD
Nortriptyline—HTR1A—central nervous system—multiple sclerosis	0.000452	0.00594	CbGeAlD
Nortriptyline—SLC6A2—central nervous system—multiple sclerosis	0.000448	0.00589	CbGeAlD
Nortriptyline—CHRM2—brain—multiple sclerosis	0.000442	0.00581	CbGeAlD
Nortriptyline—HTR1A—cerebellum—multiple sclerosis	0.000442	0.0058	CbGeAlD
Nortriptyline—ADRA1A—nervous system—multiple sclerosis	0.000433	0.00568	CbGeAlD
Nortriptyline—CYP2E1—medulla oblongata—multiple sclerosis	0.000428	0.00563	CbGeAlD
Nortriptyline—HTR2C—brain—multiple sclerosis	0.000426	0.0056	CbGeAlD
Nortriptyline—DRD2—nervous system—multiple sclerosis	0.000424	0.00557	CbGeAlD
Nortriptyline—ADRA1A—central nervous system—multiple sclerosis	0.000416	0.00547	CbGeAlD
Nortriptyline—ALB—brain—multiple sclerosis	0.000416	0.00546	CbGeAlD
Nortriptyline—DRD2—central nervous system—multiple sclerosis	0.000408	0.00536	CbGeAlD
Nortriptyline—ADRA1A—cerebellum—multiple sclerosis	0.000407	0.00535	CbGeAlD
Nortriptyline—SLC6A4—brain—multiple sclerosis	0.000404	0.00531	CbGeAlD
Nortriptyline—CHRM1—brain—multiple sclerosis	0.000402	0.00529	CbGeAlD
Nortriptyline—DRD2—cerebellum—multiple sclerosis	0.000399	0.00524	CbGeAlD
Nortriptyline—CYP2E1—spinal cord—multiple sclerosis	0.000382	0.00502	CbGeAlD
Nortriptyline—HTR2A—medulla oblongata—multiple sclerosis	0.000372	0.00489	CbGeAlD
Nortriptyline—PTGS1—spinal cord—multiple sclerosis	0.000368	0.00483	CbGeAlD
Nortriptyline—CHRM3—brain—multiple sclerosis	0.00036	0.00473	CbGeAlD
Nortriptyline—HTR1A—brain—multiple sclerosis	0.000359	0.00471	CbGeAlD
Nortriptyline—SLC6A2—brain—multiple sclerosis	0.000356	0.00467	CbGeAlD
Nortriptyline—HTR2A—midbrain—multiple sclerosis	0.00034	0.00447	CbGeAlD
Nortriptyline—HRH1—nervous system—multiple sclerosis	0.000335	0.0044	CbGeAlD
Nortriptyline—HTR2A—spinal cord—multiple sclerosis	0.000332	0.00436	CbGeAlD
Nortriptyline—ADRA1A—brain—multiple sclerosis	0.000331	0.00434	CbGeAlD
Nortriptyline—DRD2—brain—multiple sclerosis	0.000324	0.00426	CbGeAlD
Nortriptyline—HRH1—central nervous system—multiple sclerosis	0.000322	0.00424	CbGeAlD
Nortriptyline—CYP2E1—nervous system—multiple sclerosis	0.000322	0.00423	CbGeAlD
Nortriptyline—PTGS1—nervous system—multiple sclerosis	0.00031	0.00407	CbGeAlD
Nortriptyline—CYP2E1—central nervous system—multiple sclerosis	0.00031	0.00407	CbGeAlD
Nortriptyline—CYP2E1—cerebellum—multiple sclerosis	0.000303	0.00398	CbGeAlD
Nortriptyline—PTGS1—central nervous system—multiple sclerosis	0.000298	0.00392	CbGeAlD
Nortriptyline—HTR2A—nervous system—multiple sclerosis	0.00028	0.00367	CbGeAlD
Nortriptyline—HTR2A—central nervous system—multiple sclerosis	0.000269	0.00354	CbGeAlD
Nortriptyline—HTR2A—cerebellum—multiple sclerosis	0.000263	0.00346	CbGeAlD
Nortriptyline—CYP3A4—nervous system—multiple sclerosis	0.000259	0.0034	CbGeAlD
Nortriptyline—HRH1—brain—multiple sclerosis	0.000256	0.00336	CbGeAlD
Nortriptyline—CYP2D6—nervous system—multiple sclerosis	0.000255	0.00335	CbGeAlD
Nortriptyline—CYP3A4—central nervous system—multiple sclerosis	0.000249	0.00328	CbGeAlD
Nortriptyline—Convulsion—Prednisolone—multiple sclerosis	0.000248	0.00142	CcSEcCtD
Nortriptyline—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000248	0.00142	CcSEcCtD
Nortriptyline—Hypertension—Prednisolone—multiple sclerosis	0.000248	0.00142	CcSEcCtD
Nortriptyline—Eosinophilia—Methotrexate—multiple sclerosis	0.000248	0.00142	CcSEcCtD
Nortriptyline—Fatigue—Mitoxantrone—multiple sclerosis	0.000246	0.00141	CcSEcCtD
Nortriptyline—CYP2E1—brain—multiple sclerosis	0.000246	0.00323	CbGeAlD
Nortriptyline—Arrhythmia—Betamethasone—multiple sclerosis	0.000246	0.00141	CcSEcCtD
Nortriptyline—Arrhythmia—Dexamethasone—multiple sclerosis	0.000246	0.00141	CcSEcCtD
Nortriptyline—CYP2D6—central nervous system—multiple sclerosis	0.000245	0.00322	CbGeAlD
Nortriptyline—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000245	0.0014	CcSEcCtD
Nortriptyline—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000244	0.0014	CcSEcCtD
Nortriptyline—Constipation—Mitoxantrone—multiple sclerosis	0.000244	0.0014	CcSEcCtD
Nortriptyline—Alopecia—Betamethasone—multiple sclerosis	0.000243	0.00139	CcSEcCtD
Nortriptyline—Alopecia—Dexamethasone—multiple sclerosis	0.000243	0.00139	CcSEcCtD
Nortriptyline—Diarrhoea—Azathioprine—multiple sclerosis	0.000241	0.00138	CcSEcCtD
Nortriptyline—Discomfort—Prednisolone—multiple sclerosis	0.000241	0.00138	CcSEcCtD
Nortriptyline—CYP2D6—cerebellum—multiple sclerosis	0.00024	0.00315	CbGeAlD
Nortriptyline—Hallucination—Prednisone—multiple sclerosis	0.000238	0.00136	CcSEcCtD
Nortriptyline—Malaise—Triamcinolone—multiple sclerosis	0.000238	0.00136	CcSEcCtD
Nortriptyline—Pancytopenia—Methotrexate—multiple sclerosis	0.000237	0.00136	CcSEcCtD
Nortriptyline—Malaise—Methylprednisolone—multiple sclerosis	0.000237	0.00136	CcSEcCtD
Nortriptyline—PTGS1—brain—multiple sclerosis	0.000237	0.00311	CbGeAlD
Nortriptyline—Syncope—Triamcinolone—multiple sclerosis	0.000237	0.00135	CcSEcCtD
Nortriptyline—Syncope—Methylprednisolone—multiple sclerosis	0.000236	0.00135	CcSEcCtD
Nortriptyline—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000235	0.00135	CcSEcCtD
Nortriptyline—Oedema—Prednisolone—multiple sclerosis	0.000234	0.00134	CcSEcCtD
Nortriptyline—Dizziness—Azathioprine—multiple sclerosis	0.000233	0.00134	CcSEcCtD
Nortriptyline—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000232	0.00133	CcSEcCtD
Nortriptyline—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000231	0.00132	CcSEcCtD
Nortriptyline—Shock—Prednisolone—multiple sclerosis	0.00023	0.00132	CcSEcCtD
Nortriptyline—Erectile dysfunction—Methotrexate—multiple sclerosis	0.00023	0.00132	CcSEcCtD
Nortriptyline—Convulsion—Triamcinolone—multiple sclerosis	0.000229	0.00131	CcSEcCtD
Nortriptyline—Tachycardia—Prednisolone—multiple sclerosis	0.000228	0.00131	CcSEcCtD
Nortriptyline—Convulsion—Methylprednisolone—multiple sclerosis	0.000228	0.0013	CcSEcCtD
Nortriptyline—Hypertension—Triamcinolone—multiple sclerosis	0.000228	0.0013	CcSEcCtD
Nortriptyline—Hypertension—Methylprednisolone—multiple sclerosis	0.000227	0.0013	CcSEcCtD
Nortriptyline—Urticaria—Mitoxantrone—multiple sclerosis	0.000227	0.0013	CcSEcCtD
Nortriptyline—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000226	0.0013	CcSEcCtD
Nortriptyline—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000226	0.00129	CcSEcCtD
Nortriptyline—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000226	0.00129	CcSEcCtD
Nortriptyline—Vomiting—Azathioprine—multiple sclerosis	0.000224	0.00128	CcSEcCtD
Nortriptyline—Eye disorder—Prednisone—multiple sclerosis	0.000224	0.00128	CcSEcCtD
Nortriptyline—Anxiety—Methylprednisolone—multiple sclerosis	0.000223	0.00128	CcSEcCtD
Nortriptyline—Drowsiness—Methotrexate—multiple sclerosis	0.000223	0.00128	CcSEcCtD
Nortriptyline—Rash—Azathioprine—multiple sclerosis	0.000223	0.00127	CcSEcCtD
Nortriptyline—Dermatitis—Azathioprine—multiple sclerosis	0.000222	0.00127	CcSEcCtD
Nortriptyline—Flushing—Prednisone—multiple sclerosis	0.000222	0.00127	CcSEcCtD
Nortriptyline—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000222	0.00127	CcSEcCtD
Nortriptyline—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000222	0.00127	CcSEcCtD
Nortriptyline—Discomfort—Triamcinolone—multiple sclerosis	0.000222	0.00127	CcSEcCtD
Nortriptyline—Discomfort—Methylprednisolone—multiple sclerosis	0.000221	0.00127	CcSEcCtD
Nortriptyline—Headache—Azathioprine—multiple sclerosis	0.000221	0.00127	CcSEcCtD
Nortriptyline—Dry mouth—Triamcinolone—multiple sclerosis	0.00022	0.00126	CcSEcCtD
Nortriptyline—Stomatitis—Methotrexate—multiple sclerosis	0.000217	0.00124	CcSEcCtD
Nortriptyline—Confusional state—Methylprednisolone—multiple sclerosis	0.000217	0.00124	CcSEcCtD
Nortriptyline—Malaise—Dexamethasone—multiple sclerosis	0.000216	0.00124	CcSEcCtD
Nortriptyline—Malaise—Betamethasone—multiple sclerosis	0.000216	0.00124	CcSEcCtD
Nortriptyline—Oedema—Triamcinolone—multiple sclerosis	0.000215	0.00123	CcSEcCtD
Nortriptyline—Syncope—Dexamethasone—multiple sclerosis	0.000215	0.00123	CcSEcCtD
Nortriptyline—Syncope—Betamethasone—multiple sclerosis	0.000215	0.00123	CcSEcCtD
Nortriptyline—Arrhythmia—Prednisone—multiple sclerosis	0.000214	0.00122	CcSEcCtD
Nortriptyline—HTR2A—brain—multiple sclerosis	0.000214	0.00281	CbGeAlD
Nortriptyline—Sweating—Methotrexate—multiple sclerosis	0.000214	0.00122	CcSEcCtD
Nortriptyline—Shock—Triamcinolone—multiple sclerosis	0.000212	0.00121	CcSEcCtD
Nortriptyline—Insomnia—Prednisolone—multiple sclerosis	0.000212	0.00121	CcSEcCtD
Nortriptyline—Alopecia—Prednisone—multiple sclerosis	0.000212	0.00121	CcSEcCtD
Nortriptyline—Shock—Methylprednisolone—multiple sclerosis	0.000211	0.00121	CcSEcCtD
Nortriptyline—Loss of consciousness—Betamethasone—multiple sclerosis	0.00021	0.0012	CcSEcCtD
Nortriptyline—Loss of consciousness—Dexamethasone—multiple sclerosis	0.00021	0.0012	CcSEcCtD
Nortriptyline—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00021	0.0012	CcSEcCtD
Nortriptyline—Paraesthesia—Prednisolone—multiple sclerosis	0.00021	0.0012	CcSEcCtD
Nortriptyline—Tachycardia—Triamcinolone—multiple sclerosis	0.00021	0.0012	CcSEcCtD
Nortriptyline—Nausea—Azathioprine—multiple sclerosis	0.00021	0.0012	CcSEcCtD
Nortriptyline—Tachycardia—Methylprednisolone—multiple sclerosis	0.00021	0.0012	CcSEcCtD
Nortriptyline—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000208	0.00119	CcSEcCtD
Nortriptyline—Agranulocytosis—Methotrexate—multiple sclerosis	0.000208	0.00119	CcSEcCtD
Nortriptyline—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000208	0.00119	CcSEcCtD
Nortriptyline—Convulsion—Dexamethasone—multiple sclerosis	0.000207	0.00119	CcSEcCtD
Nortriptyline—Convulsion—Betamethasone—multiple sclerosis	0.000207	0.00119	CcSEcCtD
Nortriptyline—Hypertension—Dexamethasone—multiple sclerosis	0.000207	0.00118	CcSEcCtD
Nortriptyline—Hypertension—Betamethasone—multiple sclerosis	0.000207	0.00118	CcSEcCtD
Nortriptyline—Asthenia—Mitoxantrone—multiple sclerosis	0.000205	0.00117	CcSEcCtD
Nortriptyline—Anxiety—Dexamethasone—multiple sclerosis	0.000203	0.00116	CcSEcCtD
Nortriptyline—Anxiety—Betamethasone—multiple sclerosis	0.000203	0.00116	CcSEcCtD
Nortriptyline—Discomfort—Dexamethasone—multiple sclerosis	0.000201	0.00115	CcSEcCtD
Nortriptyline—Discomfort—Betamethasone—multiple sclerosis	0.000201	0.00115	CcSEcCtD
Nortriptyline—Hypotension—Methylprednisolone—multiple sclerosis	0.000201	0.00115	CcSEcCtD
Nortriptyline—Hepatitis—Methotrexate—multiple sclerosis	0.0002	0.00115	CcSEcCtD
Nortriptyline—Vision blurred—Prednisone—multiple sclerosis	0.000196	0.00112	CcSEcCtD
Nortriptyline—Oedema—Dexamethasone—multiple sclerosis	0.000195	0.00112	CcSEcCtD
Nortriptyline—Oedema—Betamethasone—multiple sclerosis	0.000195	0.00112	CcSEcCtD
Nortriptyline—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000195	0.00112	CcSEcCtD
Nortriptyline—CYP2D6—brain—multiple sclerosis	0.000195	0.00256	CbGeAlD
Nortriptyline—Insomnia—Triamcinolone—multiple sclerosis	0.000195	0.00111	CcSEcCtD
Nortriptyline—Insomnia—Methylprednisolone—multiple sclerosis	0.000194	0.00111	CcSEcCtD
Nortriptyline—Ill-defined disorder—Prednisone—multiple sclerosis	0.000193	0.00111	CcSEcCtD
Nortriptyline—Paraesthesia—Triamcinolone—multiple sclerosis	0.000193	0.00111	CcSEcCtD
Nortriptyline—Feeling abnormal—Prednisolone—multiple sclerosis	0.000193	0.0011	CcSEcCtD
Nortriptyline—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000193	0.0011	CcSEcCtD
Nortriptyline—Shock—Dexamethasone—multiple sclerosis	0.000192	0.0011	CcSEcCtD
Nortriptyline—Shock—Betamethasone—multiple sclerosis	0.000192	0.0011	CcSEcCtD
Nortriptyline—Agitation—Prednisone—multiple sclerosis	0.000192	0.0011	CcSEcCtD
Nortriptyline—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000191	0.00109	CcSEcCtD
Nortriptyline—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000191	0.00109	CcSEcCtD
Nortriptyline—Tachycardia—Dexamethasone—multiple sclerosis	0.000191	0.00109	CcSEcCtD
Nortriptyline—Tachycardia—Betamethasone—multiple sclerosis	0.000191	0.00109	CcSEcCtD
Nortriptyline—Dyspepsia—Triamcinolone—multiple sclerosis	0.000189	0.00108	CcSEcCtD
Nortriptyline—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000189	0.00108	CcSEcCtD
Nortriptyline—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000189	0.00108	CcSEcCtD
Nortriptyline—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000189	0.00108	CcSEcCtD
Nortriptyline—Malaise—Prednisone—multiple sclerosis	0.000188	0.00108	CcSEcCtD
Nortriptyline—Eye disorder—Methotrexate—multiple sclerosis	0.000187	0.00107	CcSEcCtD
Nortriptyline—Syncope—Prednisone—multiple sclerosis	0.000187	0.00107	CcSEcCtD
Nortriptyline—Tinnitus—Methotrexate—multiple sclerosis	0.000187	0.00107	CcSEcCtD
Nortriptyline—Anorexia—Betamethasone—multiple sclerosis	0.000186	0.00107	CcSEcCtD
Nortriptyline—Anorexia—Dexamethasone—multiple sclerosis	0.000186	0.00107	CcSEcCtD
Nortriptyline—Urticaria—Prednisolone—multiple sclerosis	0.000186	0.00106	CcSEcCtD
Nortriptyline—Fatigue—Triamcinolone—multiple sclerosis	0.000186	0.00106	CcSEcCtD
Nortriptyline—Fatigue—Methylprednisolone—multiple sclerosis	0.000185	0.00106	CcSEcCtD
Nortriptyline—Loss of consciousness—Prednisone—multiple sclerosis	0.000183	0.00105	CcSEcCtD
Nortriptyline—Hypotension—Betamethasone—multiple sclerosis	0.000183	0.00104	CcSEcCtD
Nortriptyline—Hypotension—Dexamethasone—multiple sclerosis	0.000183	0.00104	CcSEcCtD
Nortriptyline—Vomiting—Mitoxantrone—multiple sclerosis	0.000181	0.00104	CcSEcCtD
Nortriptyline—Convulsion—Prednisone—multiple sclerosis	0.000181	0.00103	CcSEcCtD
Nortriptyline—Hypertension—Prednisone—multiple sclerosis	0.00018	0.00103	CcSEcCtD
Nortriptyline—Rash—Mitoxantrone—multiple sclerosis	0.00018	0.00103	CcSEcCtD
Nortriptyline—Dermatitis—Mitoxantrone—multiple sclerosis	0.00018	0.00103	CcSEcCtD
Nortriptyline—Headache—Mitoxantrone—multiple sclerosis	0.000179	0.00102	CcSEcCtD
Nortriptyline—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000177	0.00102	CcSEcCtD
Nortriptyline—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000177	0.00101	CcSEcCtD
Nortriptyline—Anxiety—Prednisone—multiple sclerosis	0.000177	0.00101	CcSEcCtD
Nortriptyline—Alopecia—Methotrexate—multiple sclerosis	0.000177	0.00101	CcSEcCtD
Nortriptyline—Insomnia—Betamethasone—multiple sclerosis	0.000177	0.00101	CcSEcCtD
Nortriptyline—Insomnia—Dexamethasone—multiple sclerosis	0.000177	0.00101	CcSEcCtD
Nortriptyline—Paraesthesia—Dexamethasone—multiple sclerosis	0.000175	0.001	CcSEcCtD
Nortriptyline—Paraesthesia—Betamethasone—multiple sclerosis	0.000175	0.001	CcSEcCtD
Nortriptyline—Discomfort—Prednisone—multiple sclerosis	0.000175	0.001	CcSEcCtD
Nortriptyline—Hypersensitivity—Prednisolone—multiple sclerosis	0.000172	0.000987	CcSEcCtD
Nortriptyline—Dyspepsia—Betamethasone—multiple sclerosis	0.000172	0.000984	CcSEcCtD
Nortriptyline—Dyspepsia—Dexamethasone—multiple sclerosis	0.000172	0.000984	CcSEcCtD
Nortriptyline—Urticaria—Triamcinolone—multiple sclerosis	0.000171	0.000979	CcSEcCtD
Nortriptyline—Urticaria—Methylprednisolone—multiple sclerosis	0.000171	0.000977	CcSEcCtD
Nortriptyline—Dysgeusia—Methotrexate—multiple sclerosis	0.000171	0.000976	CcSEcCtD
Nortriptyline—Body temperature increased—Triamcinolone—multiple sclerosis	0.00017	0.000974	CcSEcCtD
Nortriptyline—Oedema—Prednisone—multiple sclerosis	0.00017	0.000973	CcSEcCtD
Nortriptyline—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00017	0.000972	CcSEcCtD
Nortriptyline—Decreased appetite—Dexamethasone—multiple sclerosis	0.00017	0.000972	CcSEcCtD
Nortriptyline—Decreased appetite—Betamethasone—multiple sclerosis	0.00017	0.000972	CcSEcCtD
Nortriptyline—Nausea—Mitoxantrone—multiple sclerosis	0.000169	0.00097	CcSEcCtD
Nortriptyline—Fatigue—Betamethasone—multiple sclerosis	0.000168	0.000964	CcSEcCtD
Nortriptyline—Fatigue—Dexamethasone—multiple sclerosis	0.000168	0.000964	CcSEcCtD
Nortriptyline—Shock—Prednisone—multiple sclerosis	0.000167	0.000958	CcSEcCtD
Nortriptyline—Tachycardia—Prednisone—multiple sclerosis	0.000166	0.00095	CcSEcCtD
Nortriptyline—Hyperhidrosis—Prednisone—multiple sclerosis	0.000164	0.000941	CcSEcCtD
Nortriptyline—Vision blurred—Methotrexate—multiple sclerosis	0.000164	0.000939	CcSEcCtD
Nortriptyline—Anorexia—Prednisone—multiple sclerosis	0.000162	0.000928	CcSEcCtD
Nortriptyline—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000162	0.000925	CcSEcCtD
Nortriptyline—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000161	0.000921	CcSEcCtD
Nortriptyline—Feeling abnormal—Betamethasone—multiple sclerosis	0.000161	0.000921	CcSEcCtD
Nortriptyline—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000159	0.000908	CcSEcCtD
Nortriptyline—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000158	0.000906	CcSEcCtD
Nortriptyline—Malaise—Methotrexate—multiple sclerosis	0.000157	0.000899	CcSEcCtD
Nortriptyline—Leukopenia—Methotrexate—multiple sclerosis	0.000156	0.000892	CcSEcCtD
Nortriptyline—Urticaria—Betamethasone—multiple sclerosis	0.000155	0.000888	CcSEcCtD
Nortriptyline—Urticaria—Dexamethasone—multiple sclerosis	0.000155	0.000888	CcSEcCtD
Nortriptyline—Dizziness—Prednisolone—multiple sclerosis	0.000155	0.000886	CcSEcCtD
Nortriptyline—Asthenia—Triamcinolone—multiple sclerosis	0.000154	0.000884	CcSEcCtD
Nortriptyline—Abdominal pain—Betamethasone—multiple sclerosis	0.000154	0.000884	CcSEcCtD
Nortriptyline—Abdominal pain—Dexamethasone—multiple sclerosis	0.000154	0.000884	CcSEcCtD
Nortriptyline—Body temperature increased—Betamethasone—multiple sclerosis	0.000154	0.000884	CcSEcCtD
Nortriptyline—Body temperature increased—Dexamethasone—multiple sclerosis	0.000154	0.000884	CcSEcCtD
Nortriptyline—Asthenia—Methylprednisolone—multiple sclerosis	0.000154	0.000882	CcSEcCtD
Nortriptyline—Insomnia—Prednisone—multiple sclerosis	0.000154	0.00088	CcSEcCtD
Nortriptyline—Paraesthesia—Prednisone—multiple sclerosis	0.000153	0.000874	CcSEcCtD
Nortriptyline—Pruritus—Triamcinolone—multiple sclerosis	0.000152	0.000872	CcSEcCtD
Nortriptyline—Pruritus—Methylprednisolone—multiple sclerosis	0.000152	0.00087	CcSEcCtD
Nortriptyline—Convulsion—Methotrexate—multiple sclerosis	0.000151	0.000864	CcSEcCtD
Nortriptyline—Dyspepsia—Prednisone—multiple sclerosis	0.00015	0.000857	CcSEcCtD
Nortriptyline—Decreased appetite—Prednisone—multiple sclerosis	0.000148	0.000846	CcSEcCtD
Nortriptyline—Rash—Prednisolone—multiple sclerosis	0.000148	0.000845	CcSEcCtD
Nortriptyline—Dermatitis—Prednisolone—multiple sclerosis	0.000147	0.000844	CcSEcCtD
Nortriptyline—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000147	0.000841	CcSEcCtD
Nortriptyline—Fatigue—Prednisone—multiple sclerosis	0.000147	0.000839	CcSEcCtD
Nortriptyline—Headache—Prednisolone—multiple sclerosis	0.000147	0.000839	CcSEcCtD
Nortriptyline—Discomfort—Methotrexate—multiple sclerosis	0.000147	0.000839	CcSEcCtD
Nortriptyline—Constipation—Prednisone—multiple sclerosis	0.000145	0.000832	CcSEcCtD
Nortriptyline—Confusional state—Methotrexate—multiple sclerosis	0.000143	0.00082	CcSEcCtD
Nortriptyline—Dizziness—Triamcinolone—multiple sclerosis	0.000142	0.000815	CcSEcCtD
Nortriptyline—Dizziness—Methylprednisolone—multiple sclerosis	0.000142	0.000813	CcSEcCtD
Nortriptyline—Feeling abnormal—Prednisone—multiple sclerosis	0.00014	0.000802	CcSEcCtD
Nortriptyline—Asthenia—Betamethasone—multiple sclerosis	0.00014	0.000802	CcSEcCtD
Nortriptyline—Asthenia—Dexamethasone—multiple sclerosis	0.00014	0.000802	CcSEcCtD
Nortriptyline—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000139	0.000797	CcSEcCtD
Nortriptyline—Nausea—Prednisolone—multiple sclerosis	0.000139	0.000796	CcSEcCtD
Nortriptyline—Pruritus—Dexamethasone—multiple sclerosis	0.000138	0.000791	CcSEcCtD
Nortriptyline—Pruritus—Betamethasone—multiple sclerosis	0.000138	0.000791	CcSEcCtD
Nortriptyline—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000137	0.000786	CcSEcCtD
Nortriptyline—Vomiting—Triamcinolone—multiple sclerosis	0.000137	0.000783	CcSEcCtD
Nortriptyline—Vomiting—Methylprednisolone—multiple sclerosis	0.000137	0.000782	CcSEcCtD
Nortriptyline—Rash—Triamcinolone—multiple sclerosis	0.000136	0.000777	CcSEcCtD
Nortriptyline—Dermatitis—Triamcinolone—multiple sclerosis	0.000136	0.000776	CcSEcCtD
Nortriptyline—Anorexia—Methotrexate—multiple sclerosis	0.000136	0.000775	CcSEcCtD
Nortriptyline—Rash—Methylprednisolone—multiple sclerosis	0.000135	0.000775	CcSEcCtD
Nortriptyline—Dermatitis—Methylprednisolone—multiple sclerosis	0.000135	0.000774	CcSEcCtD
Nortriptyline—Urticaria—Prednisone—multiple sclerosis	0.000135	0.000773	CcSEcCtD
Nortriptyline—Headache—Triamcinolone—multiple sclerosis	0.000135	0.000772	CcSEcCtD
Nortriptyline—Headache—Methylprednisolone—multiple sclerosis	0.000135	0.00077	CcSEcCtD
Nortriptyline—Abdominal pain—Prednisone—multiple sclerosis	0.000134	0.00077	CcSEcCtD
Nortriptyline—Body temperature increased—Prednisone—multiple sclerosis	0.000134	0.00077	CcSEcCtD
Nortriptyline—Diarrhoea—Betamethasone—multiple sclerosis	0.000134	0.000765	CcSEcCtD
Nortriptyline—Diarrhoea—Dexamethasone—multiple sclerosis	0.000134	0.000765	CcSEcCtD
Nortriptyline—Hypotension—Methotrexate—multiple sclerosis	0.000133	0.00076	CcSEcCtD
Nortriptyline—Dizziness—Dexamethasone—multiple sclerosis	0.000129	0.000739	CcSEcCtD
Nortriptyline—Dizziness—Betamethasone—multiple sclerosis	0.000129	0.000739	CcSEcCtD
Nortriptyline—Insomnia—Methotrexate—multiple sclerosis	0.000129	0.000736	CcSEcCtD
Nortriptyline—Nausea—Triamcinolone—multiple sclerosis	0.000128	0.000732	CcSEcCtD
Nortriptyline—Paraesthesia—Methotrexate—multiple sclerosis	0.000128	0.000731	CcSEcCtD
Nortriptyline—Nausea—Methylprednisolone—multiple sclerosis	0.000128	0.00073	CcSEcCtD
Nortriptyline—Somnolence—Methotrexate—multiple sclerosis	0.000126	0.000723	CcSEcCtD
Nortriptyline—Hypersensitivity—Prednisone—multiple sclerosis	0.000125	0.000717	CcSEcCtD
Nortriptyline—Dyspepsia—Methotrexate—multiple sclerosis	0.000125	0.000716	CcSEcCtD
Nortriptyline—Vomiting—Dexamethasone—multiple sclerosis	0.000124	0.000711	CcSEcCtD
Nortriptyline—Vomiting—Betamethasone—multiple sclerosis	0.000124	0.000711	CcSEcCtD
Nortriptyline—Decreased appetite—Methotrexate—multiple sclerosis	0.000124	0.000707	CcSEcCtD
Nortriptyline—Rash—Dexamethasone—multiple sclerosis	0.000123	0.000705	CcSEcCtD
Nortriptyline—Rash—Betamethasone—multiple sclerosis	0.000123	0.000705	CcSEcCtD
Nortriptyline—Dermatitis—Dexamethasone—multiple sclerosis	0.000123	0.000704	CcSEcCtD
Nortriptyline—Dermatitis—Betamethasone—multiple sclerosis	0.000123	0.000704	CcSEcCtD
Nortriptyline—Fatigue—Methotrexate—multiple sclerosis	0.000123	0.000701	CcSEcCtD
Nortriptyline—Headache—Dexamethasone—multiple sclerosis	0.000122	0.0007	CcSEcCtD
Nortriptyline—Headache—Betamethasone—multiple sclerosis	0.000122	0.0007	CcSEcCtD
Nortriptyline—Asthenia—Prednisone—multiple sclerosis	0.000122	0.000698	CcSEcCtD
Nortriptyline—Pruritus—Prednisone—multiple sclerosis	0.00012	0.000689	CcSEcCtD
Nortriptyline—Feeling abnormal—Methotrexate—multiple sclerosis	0.000117	0.00067	CcSEcCtD
Nortriptyline—Diarrhoea—Prednisone—multiple sclerosis	0.000116	0.000666	CcSEcCtD
Nortriptyline—Nausea—Dexamethasone—multiple sclerosis	0.000116	0.000664	CcSEcCtD
Nortriptyline—Nausea—Betamethasone—multiple sclerosis	0.000116	0.000664	CcSEcCtD
Nortriptyline—Urticaria—Methotrexate—multiple sclerosis	0.000113	0.000646	CcSEcCtD
Nortriptyline—Dizziness—Prednisone—multiple sclerosis	0.000112	0.000644	CcSEcCtD
Nortriptyline—Abdominal pain—Methotrexate—multiple sclerosis	0.000112	0.000643	CcSEcCtD
Nortriptyline—Body temperature increased—Methotrexate—multiple sclerosis	0.000112	0.000643	CcSEcCtD
Nortriptyline—Vomiting—Prednisone—multiple sclerosis	0.000108	0.000619	CcSEcCtD
Nortriptyline—Rash—Prednisone—multiple sclerosis	0.000107	0.000614	CcSEcCtD
Nortriptyline—Dermatitis—Prednisone—multiple sclerosis	0.000107	0.000613	CcSEcCtD
Nortriptyline—Headache—Prednisone—multiple sclerosis	0.000107	0.00061	CcSEcCtD
Nortriptyline—Hypersensitivity—Methotrexate—multiple sclerosis	0.000105	0.000599	CcSEcCtD
Nortriptyline—Asthenia—Methotrexate—multiple sclerosis	0.000102	0.000584	CcSEcCtD
Nortriptyline—Nausea—Prednisone—multiple sclerosis	0.000101	0.000578	CcSEcCtD
Nortriptyline—Pruritus—Methotrexate—multiple sclerosis	0.000101	0.000576	CcSEcCtD
Nortriptyline—Diarrhoea—Methotrexate—multiple sclerosis	9.73e-05	0.000557	CcSEcCtD
Nortriptyline—Dizziness—Methotrexate—multiple sclerosis	9.4e-05	0.000538	CcSEcCtD
Nortriptyline—Vomiting—Methotrexate—multiple sclerosis	9.04e-05	0.000517	CcSEcCtD
Nortriptyline—Rash—Methotrexate—multiple sclerosis	8.96e-05	0.000513	CcSEcCtD
Nortriptyline—Dermatitis—Methotrexate—multiple sclerosis	8.95e-05	0.000512	CcSEcCtD
Nortriptyline—Headache—Methotrexate—multiple sclerosis	8.91e-05	0.00051	CcSEcCtD
Nortriptyline—Nausea—Methotrexate—multiple sclerosis	8.44e-05	0.000483	CcSEcCtD
Nortriptyline—CHRM3—Metabolism—APOE—multiple sclerosis	9.43e-06	8.48e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—IL2—multiple sclerosis	9.42e-06	8.47e-05	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—IL2—multiple sclerosis	9.41e-06	8.46e-05	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—IL2—multiple sclerosis	9.39e-06	8.44e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—BCHE—multiple sclerosis	9.37e-06	8.42e-05	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—IL2—multiple sclerosis	9.36e-06	8.42e-05	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—IL2—multiple sclerosis	9.33e-06	8.39e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—BCHE—multiple sclerosis	9.29e-06	8.35e-05	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	9.24e-06	8.31e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—MAPK1—multiple sclerosis	9.24e-06	8.3e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	9.22e-06	8.29e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.21e-06	8.28e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—APOE—multiple sclerosis	9.2e-06	8.27e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—APOE—multiple sclerosis	9.16e-06	8.23e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—POMC—multiple sclerosis	9.13e-06	8.21e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—SPP1—multiple sclerosis	9.13e-06	8.21e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—POMC—multiple sclerosis	9.07e-06	8.16e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—SPP1—multiple sclerosis	8.98e-06	8.08e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—SPP1—multiple sclerosis	8.96e-06	8.06e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TYK2—multiple sclerosis	8.95e-06	8.05e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—SPP1—multiple sclerosis	8.94e-06	8.03e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—SPP1—multiple sclerosis	8.91e-06	8.01e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CCR5—multiple sclerosis	8.88e-06	7.99e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CCL2—multiple sclerosis	8.88e-06	7.98e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	8.82e-06	7.93e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	8.8e-06	7.91e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—APOE—multiple sclerosis	8.76e-06	7.88e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IL2RA—multiple sclerosis	8.75e-06	7.87e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CCR5—multiple sclerosis	8.74e-06	7.86e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CCR5—multiple sclerosis	8.72e-06	7.84e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CCR5—multiple sclerosis	8.69e-06	7.82e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—IL2—multiple sclerosis	8.69e-06	7.81e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—MAPK1—multiple sclerosis	8.68e-06	7.81e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CCR5—multiple sclerosis	8.66e-06	7.79e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IL2RA—multiple sclerosis	8.61e-06	7.74e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IL2RA—multiple sclerosis	8.59e-06	7.73e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	8.58e-06	7.71e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TYK2—multiple sclerosis	8.57e-06	7.71e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IL2RA—multiple sclerosis	8.57e-06	7.7e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	8.56e-06	7.69e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—IL2—multiple sclerosis	8.55e-06	7.68e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IL2RA—multiple sclerosis	8.54e-06	7.68e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—IL2—multiple sclerosis	8.53e-06	7.67e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—IL2—multiple sclerosis	8.5e-06	7.64e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—IL2—multiple sclerosis	8.47e-06	7.62e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	8.46e-06	7.6e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	8.43e-06	7.58e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.4e-06	7.55e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	8.39e-06	7.55e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	8.37e-06	7.52e-05	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—TGFB1—multiple sclerosis	8.34e-06	7.5e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—ALB—multiple sclerosis	8.32e-06	7.49e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CD80—multiple sclerosis	8.32e-06	7.48e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CD80—multiple sclerosis	8.28e-06	7.44e-05	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—MAPK1—multiple sclerosis	8.18e-06	7.35e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—POMC—multiple sclerosis	8.1e-06	7.28e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—APOE—multiple sclerosis	8.08e-06	7.26e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TYK2—multiple sclerosis	8.06e-06	7.25e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—APOE—multiple sclerosis	7.95e-06	7.15e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—APOE—multiple sclerosis	7.94e-06	7.14e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—BCHE—multiple sclerosis	7.94e-06	7.14e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—APOE—multiple sclerosis	7.93e-06	7.13e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—APOE—multiple sclerosis	7.93e-06	7.13e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CD80—multiple sclerosis	7.92e-06	7.12e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—APOE—multiple sclerosis	7.91e-06	7.11e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—POMC—multiple sclerosis	7.91e-06	7.11e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—IL2—multiple sclerosis	7.9e-06	7.1e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—APOE—multiple sclerosis	7.88e-06	7.09e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—POMC—multiple sclerosis	7.86e-06	7.07e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—IL6—multiple sclerosis	7.86e-06	7.06e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—APOE—multiple sclerosis	7.81e-06	7.02e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	7.78e-06	7e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	7.74e-06	6.95e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CCL2—multiple sclerosis	7.7e-06	6.92e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	7.57e-06	6.8e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—MAPK1—multiple sclerosis	7.53e-06	6.77e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—POMC—multiple sclerosis	7.53e-06	6.77e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—MMP9—multiple sclerosis	7.47e-06	6.72e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—IL2—multiple sclerosis	7.45e-06	6.7e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—IL6—multiple sclerosis	7.41e-06	6.66e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—ALB—multiple sclerosis	7.38e-06	6.64e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CCL2—multiple sclerosis	7.37e-06	6.62e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CD80—multiple sclerosis	7.31e-06	6.57e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—MAPK1—multiple sclerosis	7.21e-06	6.48e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CD80—multiple sclerosis	7.19e-06	6.46e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CD80—multiple sclerosis	7.17e-06	6.45e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CD80—multiple sclerosis	7.15e-06	6.43e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IL2—multiple sclerosis	7.13e-06	6.41e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CD80—multiple sclerosis	7.13e-06	6.41e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—IL6—multiple sclerosis	7.1e-06	6.38e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CD80—multiple sclerosis	7.06e-06	6.35e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—MMP9—multiple sclerosis	7.05e-06	6.34e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	7.04e-06	6.33e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	7.02e-06	6.32e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	6.99e-06	6.28e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—POMC—multiple sclerosis	6.94e-06	6.24e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—POMC—multiple sclerosis	6.83e-06	6.14e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—APOE—multiple sclerosis	6.83e-06	6.14e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—POMC—multiple sclerosis	6.82e-06	6.14e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—POMC—multiple sclerosis	6.81e-06	6.13e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—POMC—multiple sclerosis	6.81e-06	6.12e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—POMC—multiple sclerosis	6.79e-06	6.11e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CCL2—multiple sclerosis	6.79e-06	6.11e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—POMC—multiple sclerosis	6.77e-06	6.09e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—MMP9—multiple sclerosis	6.75e-06	6.07e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IL2—multiple sclerosis	6.71e-06	6.03e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—POMC—multiple sclerosis	6.71e-06	6.03e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TYK2—multiple sclerosis	6.69e-06	6.01e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	6.69e-06	6.01e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	6.68e-06	6.01e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—IL6—multiple sclerosis	6.67e-06	6e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CCL2—multiple sclerosis	6.67e-06	6e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CCL2—multiple sclerosis	6.65e-06	5.98e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	6.64e-06	5.97e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—STAT3—multiple sclerosis	6.64e-06	5.97e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CCL2—multiple sclerosis	6.63e-06	5.96e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	6.56e-06	5.9e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	6.54e-06	5.88e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	6.54e-06	5.88e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	6.52e-06	5.87e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—MAPK1—multiple sclerosis	6.5e-06	5.85e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—MAPK1—multiple sclerosis	6.48e-06	5.83e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	6.42e-06	5.77e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	6.4e-06	5.76e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—MMP9—multiple sclerosis	6.35e-06	5.71e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—STAT3—multiple sclerosis	6.27e-06	5.64e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—ALB—multiple sclerosis	6.22e-06	5.59e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—ALB—multiple sclerosis	6.21e-06	5.58e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—MYC—multiple sclerosis	6.17e-06	5.55e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TYK2—multiple sclerosis	6.17e-06	5.54e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—TGFB1—multiple sclerosis	6.16e-06	5.54e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—APOE—multiple sclerosis	6.13e-06	5.51e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—BCHE—multiple sclerosis	6.13e-06	5.51e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	6.07e-06	5.46e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TYK2—multiple sclerosis	6.05e-06	5.44e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—MAPK1—multiple sclerosis	6.04e-06	5.43e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TYK2—multiple sclerosis	6.04e-06	5.43e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TYK2—multiple sclerosis	6.02e-06	5.41e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—STAT3—multiple sclerosis	6e-06	5.4e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	5.96e-06	5.36e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	5.94e-06	5.34e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—POMC—multiple sclerosis	5.86e-06	5.27e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IL2—multiple sclerosis	5.84e-06	5.25e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—MYC—multiple sclerosis	5.82e-06	5.24e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	5.82e-06	5.23e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IL2—multiple sclerosis	5.81e-06	5.23e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TGFB1—multiple sclerosis	5.81e-06	5.22e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	5.79e-06	5.2e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—MAPK1—multiple sclerosis	5.7e-06	5.12e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—STAT3—multiple sclerosis	5.64e-06	5.07e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—APOE—multiple sclerosis	5.64e-06	5.07e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—APOE—multiple sclerosis	5.59e-06	5.02e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—MYC—multiple sclerosis	5.58e-06	5.01e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IL2—multiple sclerosis	5.57e-06	5e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TGFB1—multiple sclerosis	5.56e-06	5e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—IL6—multiple sclerosis	5.54e-06	4.98e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	5.53e-06	4.97e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	5.5e-06	4.95e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—MAPK1—multiple sclerosis	5.46e-06	4.91e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MMP9—multiple sclerosis	5.27e-06	4.74e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—POMC—multiple sclerosis	5.26e-06	4.73e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—MYC—multiple sclerosis	5.24e-06	4.71e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TGFB1—multiple sclerosis	5.23e-06	4.7e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IL2—multiple sclerosis	5.13e-06	4.61e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—MAPK1—multiple sclerosis	5.13e-06	4.61e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—IL6—multiple sclerosis	5.11e-06	4.59e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IL2—multiple sclerosis	5.05e-06	4.54e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IL2—multiple sclerosis	5.04e-06	4.53e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	5.02e-06	4.52e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IL2—multiple sclerosis	5.02e-06	4.52e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—IL6—multiple sclerosis	5.01e-06	4.51e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IL2—multiple sclerosis	5.01e-06	4.5e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—IL6—multiple sclerosis	5e-06	4.49e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—IL6—multiple sclerosis	4.98e-06	4.48e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IL2—multiple sclerosis	4.96e-06	4.46e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	4.94e-06	4.45e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	4.93e-06	4.44e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	4.92e-06	4.42e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	4.92e-06	4.42e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	4.89e-06	4.4e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MMP9—multiple sclerosis	4.86e-06	4.37e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—POMC—multiple sclerosis	4.84e-06	4.35e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—POMC—multiple sclerosis	4.8e-06	4.32e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—ALB—multiple sclerosis	4.8e-06	4.32e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	4.78e-06	4.3e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—APOE—multiple sclerosis	4.78e-06	4.29e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MMP9—multiple sclerosis	4.77e-06	4.29e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MMP9—multiple sclerosis	4.75e-06	4.27e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MMP9—multiple sclerosis	4.74e-06	4.26e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	4.69e-06	4.22e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—STAT3—multiple sclerosis	4.68e-06	4.21e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	4.68e-06	4.21e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—IL6—multiple sclerosis	4.64e-06	4.17e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MYC—multiple sclerosis	4.57e-06	4.11e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	4.56e-06	4.1e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MYC—multiple sclerosis	4.55e-06	4.09e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	4.54e-06	4.08e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	4.47e-06	4.02e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	4.45e-06	4e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—ALB—multiple sclerosis	4.41e-06	3.97e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—IL6—multiple sclerosis	4.38e-06	3.94e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—ALB—multiple sclerosis	4.38e-06	3.93e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MYC—multiple sclerosis	4.35e-06	3.91e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TGFB1—multiple sclerosis	4.34e-06	3.9e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—STAT3—multiple sclerosis	4.32e-06	3.88e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MAPK1—multiple sclerosis	4.26e-06	3.83e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	4.25e-06	3.82e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—STAT3—multiple sclerosis	4.24e-06	3.81e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—STAT3—multiple sclerosis	4.23e-06	3.8e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—STAT3—multiple sclerosis	4.21e-06	3.79e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IL6—multiple sclerosis	4.19e-06	3.77e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	4.17e-06	3.75e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	4.16e-06	3.74e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—POMC—multiple sclerosis	4.1e-06	3.69e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MYC—multiple sclerosis	4.01e-06	3.61e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	4e-06	3.6e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MYC—multiple sclerosis	3.95e-06	3.55e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IL6—multiple sclerosis	3.94e-06	3.54e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MYC—multiple sclerosis	3.94e-06	3.54e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	3.94e-06	3.54e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	3.93e-06	3.53e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MYC—multiple sclerosis	3.93e-06	3.53e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	3.93e-06	3.53e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TGFB1—multiple sclerosis	3.92e-06	3.52e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MYC—multiple sclerosis	3.91e-06	3.52e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TGFB1—multiple sclerosis	3.9e-06	3.51e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MYC—multiple sclerosis	3.88e-06	3.49e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	3.87e-06	3.48e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	3.87e-06	3.48e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	3.86e-06	3.47e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	3.86e-06	3.47e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	3.85e-06	3.47e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MAPK1—multiple sclerosis	3.84e-06	3.45e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MAPK1—multiple sclerosis	3.83e-06	3.44e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	3.79e-06	3.41e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	3.78e-06	3.4e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—ALB—multiple sclerosis	3.74e-06	3.36e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—APOE—multiple sclerosis	3.69e-06	3.31e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IL6—multiple sclerosis	3.44e-06	3.09e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IL6—multiple sclerosis	3.42e-06	3.07e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IL6—multiple sclerosis	3.27e-06	2.94e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—POMC—multiple sclerosis	3.17e-06	2.85e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IL6—multiple sclerosis	3.02e-06	2.71e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IL6—multiple sclerosis	2.97e-06	2.67e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IL6—multiple sclerosis	2.96e-06	2.66e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IL6—multiple sclerosis	2.95e-06	2.65e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IL6—multiple sclerosis	2.94e-06	2.65e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IL6—multiple sclerosis	2.91e-06	2.62e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	2.91e-06	2.61e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ALB—multiple sclerosis	2.89e-06	2.6e-05	CbGpPWpGaD
